EVP R&D, Chief Medical Officer
Mon, Nov 11, 2024
Nov 11
43,058 shares @ $20.03
Increased holdings by +43.40%
12th largest trade (out of 152)
Trade made by an officer
10b5-1 scheduled trade
0% win rate · -16.0% median edge vs SPY (5 trades, 90-day · small sample)
Insider trade was 33% below market price
Price 13% above 200-day moving average